Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Arpad Szallasi
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Chemicals & Drugs
Living Beings
Anatomy
Disorders
Physiology
Procedures
Sign-in to see full Profile
Network (preview)
23
Blumberg, Peter
11
Lundberg, Jan
9
Hökfelt, Tomas
6
Cortright, Daniel
6
Krause, James
5
Appendino, Giovanni
4
Bíró, Tamás
4
Sterner, Olov
3
Wiesenfeld-Hallin, Zsuzsanna
3
Modarres, S
3
Farkas-Szallasi, T
2
Di Marzo, Vincenzo
2
Szabó, Tamás
2
Xu, Xiao-Jun
1
Zhang, Qian
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Arpad Szallasi (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Cortright Daniel N; Szallasi Arpad
TRP channels and pain.
Current pharmaceutical design 2009;15(15):1736-49.
-
2008: Di Marzo Vincenzo; Gobbi Gabriella; Szallasi Arpad
Brain TRPV1: a depressing TR(i)P down memory lane?
Trends in pharmacological sciences 2008;29(12):594-600.
-
2008: Fanghong Li; Szallasi Arpad; Young Robert H
Wolffian tumor of the ovary with a prominent spindle cell component: report of a case with brief discussion of unusual problems in differential diagnosis, and literature review.
International journal of surgical pathology 2008;16(2):222-5.
-
2008: Knotkova Helena; Pappagallo Marco; Szallasi Arpad
Capsaicin (TRPV1 Agonist) therapy for pain relief: farewell or revival?
The Clinical journal of pain 2008;24(2):142-54.
-
2008: Suri Anish; Szallasi Arpad
The emerging role of TRPV1 in diabetes and obesity.
Trends in pharmacological sciences 2008;29(1):29-36.
-
2008: Gunthorpe Martin J; Szallasi Arpad
Peripheral TRPV1 receptors as targets for drug development: new molecules and mechanisms.
Current pharmaceutical design 2008;14(1):32-41.
-
2007: Szallasi Arpad; Cortright Daniel N; Blum Charles A; Eid Samer R
The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept.
Nature reviews. Drug discovery 2007;6(5):357-72.
-
2006: Szallasi Arpad; Cruz Francisco; Geppetti Pierangelo
TRPV1: a therapeutic target for novel analgesic drugs?
Trends in molecular medicine 2006;12(11):545-54.
-
2006: Szallasi Arpad
Small molecule vanilloid TRPV1 receptor antagonists approaching drug status: can they live up to the expectations?
Naunyn-Schmiedeberg's archives of pharmacology 2006;373(4):273-86.
-
2006: Nagasawa T; Zhang Q; Raghunath P N; Wong H Y; El-Salem M; Szallasi A; Marzec M; Gimotty P; Rook A H; Vonderheid E C; Odum N; Wasik M A
Multi-gene epigenetic silencing of tumor suppressor genes in T-cell lymphoma cells; delayed expression of the p16 protein upon reversal of the silencing.
Leukemia research 2006;30(3):303-12.
-
2006: Appendino Giovanni; Szallasi Arpad
Clinically useful vanilloid receptor TRPV1 antagonists: just around the corner (or too early to tell)?
Progress in medicinal chemistry 2006;44():145-80.
-
2005: Szallasi Arpad
Piperine: researchers discover new flavor in an ancient spice.
Trends in pharmacological sciences 2005;26(9):437-9.
-
2005: Armstrong Gregory; Szallasi Arpad; Biegel Jaclyn A; Shurtleff Sheila; Bilaniuk Larissa T; Womer Richard B; Choi John Kim
Early molecular detection of central nervous system relapse in a child with systemic anaplastic large cell lymphoma: case report and review of the literature.
Pediatric blood & cancer 2005;44(4):400-6.
-
2004: Szallasi Arpad; Appendino Giovanni
Vanilloid receptor TRPV1 antagonists as the next generation of painkillers. Are we putting the cart before the horse?
Journal of medicinal chemistry 2004;47(11):2717-23.
-
2004: Cortright Daniel N; Szallasi Arpad
Biochemical pharmacology of the vanilloid receptor TRPV1. An update.
European journal of biochemistry / FEBS 2004;271(10):1814-9.
-
2003: Szallasi Arpad; Gronowski Ann M; Eby Charles S
Lamellar body count in amniotic fluid: a comparative study of four different hematology analyzers.
Clinical chemistry 2003;49(6 Pt 1):994-7.
-
2002: Di Marzo Vincenzo; Blumberg Peter M; Szallasi Arpad
Endovanilloid signaling in pain.
Current opinion in neurobiology 2002;12(4):372-9.
-
2002: Szallasi Arpad; Fowler Clare J
After a decade of intravesical vanilloid therapy: still more questions than answers.
Lancet neurology 2002;1(3):167-72.
-
2002: Szallasi Arpad
Vanilloid (capsaicin) receptors in health and disease.
American journal of clinical pathology 2002;118(1):110-21.
-
2001: Szallasi A
Vanilloid receptor ligands: hopes and realities for the future.
Drugs & aging 2001;18(8):561-73.
-
2000: Mezey E; Tóth Z E; Cortright D N; Arzubi M K; Krause J E; Elde R; Guo A; Blumberg P M; Szallasi A
Distribution of mRNA for vanilloid receptor subtype 1 (VR1), and VR1-like immunoreactivity, in the central nervous system of the rat and human.
Proceedings of the National Academy of Sciences of the United States of America 2000;97(7):3655-60.
-
2000: Broberger C; Farkas-Szallasi T; Szallasi A; Lundberg J M; Hökfelt T; Wiesenfeld-Hallin Z; Xu X J
Increased spinal cholecystokinin activity after systemic resiniferatoxin: electrophysiological and in situ hybridization studies.
Pain 2000;84(1):21-8.
-
1999: Szallasi A; Szabó T; Bíró T; Modarres S; Blumberg P M; Krause J E; Cortright D N; Appendino G
Resiniferatoxin-type phorboid vanilloids display capsaicin-like selectivity at native vanilloid receptors on rat DRG neurons and at the cloned vanilloid receptor VR1.
British journal of pharmacology 1999;128(2):428-34.
-
1999: Szallasi A; Blumberg P M; Annicelli L L; Krause J E; Cortright D N
The cloned rat vanilloid receptor VR1 mediates both R-type binding and C-type calcium response in dorsal root ganglion neurons.
Molecular pharmacology 1999;56(3):581-7.
-
1999: Szallasi A; Blumberg P M
Vanilloid (Capsaicin) receptors and mechanisms.
Pharmacological reviews 1999;51(2):159-212.
-
1999: Szallasi A; Bíró T; Szabó T; Modarres S; Petersen M; Klusch A; Blumberg P M; Krause J E; Sterner O
A non-pungent triprenyl phenol of fungal origin, scutigeral, stimulates rat dorsal root ganglion neurons via interaction at vanilloid receptors.
British journal of pharmacology 1999;126(6):1351-8.
-
1999: Szallasi A; Farkas-Szallasi T; Tucker J B; Lundberg J M; Hökfelt T; Krause J E
Effects of systemic resiniferatoxin treatment on substance P mRNA in rat dorsal root ganglia and substance P receptor mRNA in the spinal dorsal horn.
Brain research 1999;815(2):177-84.
-
1998: Szallasi A; Bíró T; Modarres S; Garlaschelli L; Petersen M; Klusch A; Vidari G; Jonassohn M; De Rosa S; Sterner O; Blumberg P M; Krause J E
Dialdehyde sesquiterpenes and other terpenoids as vanilloids.
European journal of pharmacology 1998;356(1):81-9.
-
1997: Jonassohn M; Hjertberg R; Anke H; Dekermendjian K; Szallasi A; Thines E; Witt R; Sterner O
The preparation and bioactivities of (-)-isovelleral.
Bioorganic & medicinal chemistry 1997;5(7):1363-7.
-
1997: Xu X J; Farkas-Szallasi T; Lundberg J M; Hökfelt T; Wiesenfeld-Hallin Z; Szallasi A
Effects of the capsaicin analogue resiniferatoxin on spinal nociceptive mechanisms in the rat: behavioral, electrophysiological and in situ hybridization studies.
Brain research 1997;752(1-2):52-60.
-
1996: Szallasi A; Jonassohn M; Acs G; Bíró T; Acs P; Blumberg P M; Sterner O
The stimulation of capsaicin-sensitive neurones in a vanilloid receptor-mediated fashion by pungent terpenoids possessing an unsaturated 1,4-dialdehyde moiety.
British journal of pharmacology 1996;119(2):283-90.
-
1996: Appendino G; Cravotto G; Palmisano G; Annunziata R; Szallasi A
Synthesis and evaluation of phorboid 20-homovanillates: discovery of a class of ligands binding to the vanilloid (capsaicin) receptor with different degrees of cooperativity.
Journal of medicinal chemistry 1996;39(16):3123-31.
-
1996: Farkas-Szallasi T; Bennett G J; Blumberg P M; Hökfelt T; Lundberg J M; Szallasi A
Vanilloid receptor loss is independent of the messenger plasticity that follows systemic resiniferatoxin administration.
Brain research 1996;719(1-2):213-8.
-
1996: Szallasi A; Acs G; Cravotto G; Blumberg P M; Lundberg J M; Appendino G
A novel agonist, phorbol 12-phenylacetate 13-acetate 20-homovanillate, abolishes positive cooperativity of binding by the vanilloid receptor.
European journal of pharmacology 1996;299(1-3):221-8.
-
1996: Szallasi A; Nilsson S; Blumberg P M; Hökfelt T; Lundberg J M
Binding of neuroleptic drugs (trifluoperazine and rimcazole) to vanilloid receptors in porcine dorsal horn.
European journal of pharmacology 1996;298(3):321-7.
-
1995: Szallasi A; Nilsson S; Farkas-Szallasi T; Blumberg P M; Hökfelt T; Lundberg J M
Vanilloid (capsaicin) receptors in the rat: distribution in the brain, regional differences in the spinal cord, axonal transport to the periphery, and depletion by systemic vanilloid treatment.
Brain research 1995;703(1-2):175-83.
-
1995: Farkas-Szallasi T; Lundberg J M; Wiesenfeld-Hallin Z; Hökfelt T; Szallasi A
Increased levels of GMAP, VIP and nitric oxide synthase, and their mRNAs, in lumbar dorsal root ganglia of the rat following systemic resiniferatoxin treatment.
Neuroreport 1995;6(16):2230-4.
-
1995: Szallasi A; Blumberg P M; Lundberg J M
Proton inhibition of [3H]resiniferatoxin binding to vanilloid (capsaicin) receptors in rat spinal cord.
European journal of pharmacology 1995;289(2):181-7.
-
1994: Szallasi A; Blumberg P M; Nilsson S; Hökfelt T; Lundberg J M
Visualization by [3H]resiniferatoxin autoradiography of capsaicin-sensitive neurons in the rat, pig and man.
European journal of pharmacology 1994;264(2):217-21.
-
1994: Szallasi A; Nilsson S; Hökfelt T; Lundberg J M
Visualizing vanilloid (capsaicin) receptors in pig spinal cord by [3H]resiniferatoxin autoradiography.
Brain research 1994;655(1-2):237-40.
-
1993: Szallasi A; Blumberg P M
[3H]resiniferatoxin binding by the vanilloid receptor: species-related differences, effects of temperature and sulfhydryl reagents.
Naunyn-Schmiedeberg's archives of pharmacology 1993;347(1):84-91.
-
1991: Szallasi A; Szolcsanyi J; Szallasi Z; Blumberg P M
Inhibition of [3H]resiniferatoxin binding to rat dorsal root ganglion membranes as a novel approach in evaluating compounds with capsaicin-like activity.
Naunyn-Schmiedeberg's archives of pharmacology 1991;344(5):551-6.
-
1991: Szallasi A; Blumberg P M
Characterization of vanilloid receptors in the dorsal horn of pig spinal cord.
Brain research 1991;547(2):335-8.
-
1990: Szallasi A; Szallasi Z; Blumberg P M
Permanent effects of neonatally administered resiniferatoxin in the rat.
Brain research 1990;537(1-2):182-6.
-
1990: Szallasi A; Blumberg P M
Specific binding of resiniferatoxin, an ultrapotent capsaicin analog, by dorsal root ganglion membranes.
Brain research 1990;524(1):106-11.
-
1989: Szallasi A; Blumberg P M
Neurogenic component of phorbol ester-induced mouse skin inflammation.
Cancer research 1989;49(21):6052-7.
-
1989: Szallasi A; Joo F; Blumberg P M
Duration of desensitization and ultrastructural changes in dorsal root ganglia in rats treated with resiniferatoxin, an ultrapotent capsaicin analog.
Brain research 1989;503(1):68-72.
-
1989: Blumberg P M; Pettit G R; Warren B S; Szallasi A; Schuman L D; Sharkey N A; Nakakuma H; Dell'Aquila M L; de Vries D J
The protein kinase C pathway in tumor promotion.
Progress in clinical and biological research 1989;298():201-12.
-
1989: Szallasi A; Blumberg P M
Resiniferatoxin, a phorbol-related diterpene, acts as an ultrapotent analog of capsaicin, the irritant constituent in red pepper.
Neuroscience 1989;30(2):515-20.
Sign-in to see more
